Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: LIPITOR

« Back to Dashboard

Summary for Tradename: LIPITOR

Patents:3
Applicants:1
NDAs:1
Suppliers: see list17

Pharmacology for Tradename: LIPITOR

Clinical Trials for: LIPITOR

CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers
Status: Not yet recruiting Condition: Healthy

Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia
Status: Completed Condition: Hypertriglyceridemia

Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus
Status: Terminated Condition: Avascular Necrosis

High Dose and Low Dose of Atorvastatin in Patients With Unstable Angina and NSTEMI (Non ST Elevation MI)
Status: Completed Condition: Cardiovascular Disease

Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.
Status: Completed Condition: HIV; Hypercholesterolaemia

Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
Status: Enrolling by invitation Condition: Sickle Cell Disease; Sickle Cell Nephropathy

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
Status: Completed Condition: Atypical Ductal Breast Hyperplasia; Breast Cancer; Ductal Breast Carcinoma in Situ; Lobular Breast Carcinoma in Situ

A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)
Status: Completed Condition: Hyperlipidemia

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
Status: Completed Condition: Dyslipidaemias

Atorvastatin for Preventing Occlusion and Restenosis After Intracranial Artery Stenting
Status: Active, not recruiting Condition: CVD

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
LIPITOR
atorvastatin calcium
TABLET;ORAL020702Apr 7, 2000RXYes5,686,104*PED<disabled>Y<disabled>
Pfizer
LIPITOR
atorvastatin calcium
TABLET;ORAL020702Dec 17, 1996RXNo5,686,104*PED<disabled>Y<disabled>
Pfizer
LIPITOR
atorvastatin calcium
TABLET;ORAL020702Apr 7, 2000RXYes5,969,156*PED<disabled>Y<disabled>
Pfizer
LIPITOR
atorvastatin calcium
TABLET;ORAL020702Dec 17, 1996RXNo6,126,971*PED<disabled><disabled>
Pfizer
LIPITOR
atorvastatin calcium
TABLET;ORAL020702Apr 7, 2000RXYes6,126,971*PED<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc